Related Experiment Video

Updated: Apr 5, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

920

Investigating the Role of JAK/STAT Pathway on Dasatinib-Induced Apoptosis for CML Cell Model K562

Ceyda Tunakan Dalgıç1, Burçin Tezcanlı Kaymaz2, Melda Cömert Özkan3

  • 1Department of Internal Medicine, Ege University Medical Faculty, İzmir, Turkey.

Clinical Lymphoma, Myeloma & Leukemia
|August 23, 2015
PubMed

Insights

Dasatinib effectively reduced proliferation and induced apoptosis in chronic myeloid leukemia (CML) cells. This drug also inhibited STAT5A and STAT5B gene expression, suggesting potential therapeutic applications.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm.
  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway plays a role in CML pathogenesis.
  • Dasatinib is a tyrosine kinase inhibitor used in CML treatment.

Purpose of the Study:

  • To evaluate the cytotoxic and apoptotic effects of dasatinib on K562 CML cells.
  • To investigate the role of STAT genes in dasatinib-induced apoptosis.

Main Methods:

  • K562 cells were treated with varying concentrations and durations of dasatinib.
  • Cell proliferation was assessed.
  • Apoptosis was measured.
  • mRNA and protein levels of STAT5A and STAT5B were analyzed.

Main Results:

  • Dasatinib significantly decreased K562 cell proliferation in a dose- and time-dependent manner.
  • Dasatinib induced apoptosis in K562 cells.
  • mRNA and protein expression of STAT5A and STAT5B were significantly reduced following dasatinib treatment.

Conclusions:

  • Dasatinib exhibits cytotoxic and apoptotic effects on K562 CML cells.
  • STAT inhibition by dasatinib may contribute to its anti-leukemic activity.
  • Targeting the JAK/STAT pathway with dasatinib shows promise for CML and other related malignancies.
Keywords:
ApoptosisChronic myeloid leukemiaDasatinibJAK/STAT pathwaySTAT5

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.3K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K